Loading…
Sectoral / Thematic · DSP Mutual Fund · AMFI code 145453DSP Healthcare Fund
Disclosed for 94 months, Dec 2018 to Sep 2026.
Portfolio value
₹281 Cr
down ₹9.6 Cr vs Feb 2020
- Stocks held
- 23
- unchanged
- Top 10 weight
- 60.6%
- of the portfolio in its ten largest
- Cash & debt
- 4.6%
- cash, money market and debt
- Moves this month
- 0 in · 0 out
- added to 10, trimmed 11
DSP Healthcare Fund is an active equity fund in the Sectoral / Thematic category from DSP Mutual Fund. In March 2020 it disclosed 23 stocks worth ₹281 Cr, down ₹9.6 Cr from Feb 2020. Its largest positions were IPCA Laboratories Limited (10.2%), Dr. Reddy's Laboratories Limited (9.8%), Divi's Laboratories Limited (8.4%); the ten largest together made up 60.6% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 67.4% of its equity. Cash and debt stood at 4.6%. Compared with Feb 2020 the fund entered 0 new stocks and exited 0.
Against 229 other Sectoral / Thematic funds
Concentration
84%
Top-10 weight is higher than 84% of peers
Breadth
6%
Holds more stocks than 6% of peers
Cash
67%
Holds more cash than 67% of peers
What these mean: concentration · cash
Holdings in March 2020
Download CSVEvery line the fund disclosed, with the change against Feb 2020. Click a column to sort; click a company to see every fund that owns it. New to these? How to read a portfolio.
| IPCA Laboratories Limited | 10.21% | up 0.56 pts | ₹28.7 Cr | up ₹64 L | Added |
| Dr. Reddy's Laboratories Limited | 9.78% | up 0.91 pts | ₹27.5 Cr | up ₹1.7 Cr | Added |
| Divi's Laboratories Limited | 8.41% | up 0.86 pts | ₹23.6 Cr | up ₹1.7 Cr | Added |
| JB Chemicals & Pharmaceuticals Limited | 7.69% | up 0.34 pts | ₹21.6 Cr | up ₹24 L | Added |
| Indoco Remedies Limited | 5.10% | down 0.30 pts | ₹14.4 Cr | down ₹1.4 Cr | Trimmed |
| Cash, TREPS & receivables | 4.57% | down 0.74 pts | ₹12.9 Cr | down ₹2.6 Cr | Trimmed |
| Sun Pharmaceutical Industries Limited | 4.32% | down 0.10 pts | ₹12.1 Cr | down ₹71 L | Trimmed |
| Procter & Gamble Health Limited | 4.14% | up 1.30 pts | ₹11.7 Cr | up ₹3.4 Cr | Added |
| Apollo Hospitals Enterprise Limited | 4.00% | down 1.89 pts | ₹11.2 Cr | down ₹5.9 Cr | Trimmed |
| Abbott Laboratories | 3.53% | up 0.36 pts | ₹9.9 Cr | up ₹70 L | Added |
| Abbott India Limited | 3.47% | up 0.06 pts | ₹9.8 Cr | down ₹17 L | Trimmed |
| Alembic Pharmaceuticals Limited | 3.23% | up 0.13 pts | ₹9.1 Cr | up ₹6 L | Added |
| Ajanta Pharma Limited | 3.21% | up 0.06 pts | ₹9 Cr | down ₹12 L | Trimmed |
| Torrent Pharmaceuticals Limited | 3.20% | down 0.17 pts | ₹9 Cr | down ₹81 L | Trimmed |
| Dr. Lal Path Labs Limited | 3.14% | up 0.69 pts | ₹8.8 Cr | up ₹1.7 Cr | Added |
| Narayana Hrudayalaya Limited | 2.98% | up 0.39 pts | ₹8.4 Cr | up ₹84 L | Added |
| Max India Limited | 2.95% | down 0.72 pts | ₹8.3 Cr | down ₹2.4 Cr | Trimmed |
| Alkem Laboratories Limited | 2.86% | down 0.26 pts | ₹8.1 Cr | down ₹1 Cr | Trimmed |
| Abiomed Inc | 2.60% | up 0.17 pts | ₹7.3 Cr | up ₹25 L | Added |
| Syngene International Limited | 2.45% | down 0.51 pts | ₹6.9 Cr | down ₹1.7 Cr | Trimmed |
| Unichem Laboratories Limited | 2.41% | up 0.41 pts | ₹6.8 Cr | up ₹97 L | Added |
| Aarti Drugs Limited | 2.13% | down 0.71 pts | ₹6 Cr | down ₹2.3 Cr | Trimmed |
| ICICI Lombard General Insurance Company Limited | 1.96% | up 0.79 pts | ₹5.5 Cr | up ₹2.1 Cr | Added |
| Jubilant Pharmova Limited | 1.67% | down 1.61 pts | ₹4.7 Cr | down ₹4.8 Cr | Trimmed |
What changed, Feb 2020 to Mar 2020
New New positions (0)
None.
Exited Exited (0)
None.
Added Biggest additions
- Procter & Gamble Health Limitedup ₹3.4 Cr (+1.30% pts)
- ICICI Lombard General Insurance Company Limitedup ₹2.1 Cr (+0.79% pts)
- Dr. Reddy's Laboratories Limitedup ₹1.7 Cr (+0.91% pts)
- Dr. Lal Path Labs Limitedup ₹1.7 Cr (+0.69% pts)
- Divi's Laboratories Limited
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Feb 2020, the weight rose most in Pharmaceuticals & Biotechnology (+0.9 pts) and Insurance (+0.8 pts), and fell most in Healthcare Services (−2.1 pts).
- Pharmaceuticals & Biotechnology66.5% → 67.4%+0.9 pts
- Insurance1.2% → 2.1%+0.8 pts
- Pharmaceuticals11.2% → 11.6%+0.4 pts
- Healthcare Services21.1% → 19.0%−2.1 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Mar 2019 | Sep 2019 | Dec 2019 | Feb 2020 | Mar 2020 |
|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 70.6% | 69.2% | 67.9% | 66.5% | 67.4% |
| Healthcare Services | 15.1% | 17.7% | 19.1% | 21.1% | 19.0% |
| Pharmaceuticals | 11.9% | 11.5% | 11.3% | 11.2% | 11.6% |
| Insurance | 2.3% | 1.6% | 1.6% | 1.2% | 2.1% |
Allocation in Mar 2020change vs Feb 2020
- Pharmaceuticals & Biotechnology (13)67.4%▲ 0.9 pts
- Healthcare Services (6)19.0%▼ 2.1 pts
- Pharmaceuticals (3)11.6%▲ 0.4 pts
- Insurance (1)
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal. More on reading cash.
Cash & debt, Mar 2020
4.6%
▼ 0.7 pts vs Feb 2020
- Cash alone
- 4.6%
- cash and net receivables
- A year earlier
- 9.2%
- Mar 2019 · now ▼ 4.7 pts
- Last 12 months
- 1.7% – 6.5%
- lowest to highest · record 28.6% in Dec 2018
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.